NICOTINE POLACRILEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nicotine Polacrilex, and what generic alternatives are available?
Nicotine Polacrilex is a drug marketed by Fertin Pharma, Ivax Sub Teva Pharms, L Perrigo Co, P And L, Perrigo R And D, Aurobindo Pharma, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, Pld Acquisitions, and Ppi-dac. and is included in forty-nine NDAs.
The generic ingredient in NICOTINE POLACRILEX is nicotine polacrilex. There are thirty drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nicotine Polacrilex
A generic version of NICOTINE POLACRILEX was approved as nicotine polacrilex by P AND L on March 15th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NICOTINE POLACRILEX?
- What are the global sales for NICOTINE POLACRILEX?
- What is Average Wholesale Price for NICOTINE POLACRILEX?
Summary for NICOTINE POLACRILEX
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 49 |
| Finished Product Suppliers / Packagers: | 60 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 22 |
| Patent Applications: | 4,453 |
| Drug Prices: | Drug price information for NICOTINE POLACRILEX |
| DailyMed Link: | NICOTINE POLACRILEX at DailyMed |
See drug prices for NICOTINE POLACRILEX
Recent Clinical Trials for NICOTINE POLACRILEX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GlaxoSmithKline | Phase 1 |
| 22nd Century Group, Inc. | Phase 1 |
| Vince & Associates Clinical Research, Inc. | Phase 1 |
Pharmacology for NICOTINE POLACRILEX
| Drug Class | Cholinergic Nicotinic Agonist |
Anatomical Therapeutic Chemical (ATC) Classes for NICOTINE POLACRILEX
Paragraph IV (Patent) Challenges for NICOTINE POLACRILEX
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| NICORETTE | Troche/Lozenge (Mini) | nicotine polacrilex | 2 mg and 4 mg | 022360 | 1 | 2015-12-02 |
US Patents and Regulatory Information for NICOTINE POLACRILEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 213233-002 | Aug 4, 2020 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 213266-001 | Aug 3, 2021 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| P And L | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 212057-001 | May 14, 2020 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Perrigo R And D | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 077007-002 | Jan 31, 2006 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| P And L | NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 209520-001 | Oct 31, 2019 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
